Start with the problem: what usually goes wrong
You need reliable data, a realistic timeline, and a partner who won’t ghost you mid-study—yet procurement often gets stuck on price only. That’s how scope creep, unclear endpoints, and surprise costs become the default. If your requirement touches kidney or urinary disease models, make sure your search explicitly covers preclinical CRO urology so proposals aren’t comparing apples to surgical mice.
Define outcomes, not tasks
Write measurable study endpoints up front. Say whether you want histology scores, renal function metrics, pharmacokinetics, or survival curves. Avoid vague language like “standard assessments.” A vendor should map methods to your endpoints and note exact assays, instruments, and acceptance criteria. Hold them to that map throughout negotiation.
Model selection and scientific fit
Pick models that answer your question, not those that are just convenient. For chronic kidney disease work, model choice alters everything—disease induction method, timing, and sample handling. At ASN Kidney Week researchers noted variable readouts across induction protocols, underscoring reproducibility problems that procurement must anticipate. Evaluate vendors by their hands-on experience with the exact model you need; for example, confirm capabilities with a CKD mouse model and ask for protocol versions and representative results.
Technical capabilities checklist
Require documentation and evidence for: surgical skill levels, anesthesia and analgesia protocols, telemetry or metabolic cages if needed, validated assays with LLOQs, GLP or GLP-like lab practices, and contingency plans for morbidity/mortality. Ask for CVs of key technical staff and examples of past reports with raw data snippets (blinded if necessary). If they can’t show technical detail, assume the risk shifts to you.
Data integrity and deliverables
Insist on raw-data access, audit trails, timestamped files, and predefined file formats. Define interim deliverables and data review gates. Require a sample final report outline and a dataset dictionary. Clarify whether images, histology slides, or wet-lab samples will be returned or retained and what metadata accompanies them.
Regulatory and animal welfare compliance
Confirm IACUC approval processes, local licensing, and housing standards. If GLP is required, require proof of GLP certification or a clear statement about non-GLP status and how they maintain quality. Ask for veterinary oversight details and perioperative mortality thresholds. Noncompliance later equals wasted budget.
Contract essentials and rights
Spell out data ownership, publication rights, and IP clauses. Define liability caps, indemnities, and intellectual property carve-outs. Include a practical dispute-resolution path and an exit strategy for study termination or reproducibility failures. Put timelines and milestone payments into the contract so payment follows verified progress.
Budget realism and hidden costs
Line-item the budget: model induction costs, animal numbers with justification, sample analysis, biohazard disposal, shipping, and archiving. Add a contingency for unexpected mortality or assay repeats. Vendors often lowball anesthesia or histology costs—confirm pricing for each deliverable. Ask how they handle currency fluctuation and VAT to avoid last-minute overruns.
Common procurement pitfalls
Don’t accept vague SLAs, verbal promises, or “standard” procedures. Avoid one-off agreements without reproducibility metrics. Don’t delegate all QC to the vendor: retain the right to audit, review raw data, and request re-runs if acceptance criteria aren’t met. Beware vendors that resist sharing SOPs or staff qualifications—that’s a red flag.
Alternatives and when to choose them
Compare in-house execution, partnering with an academic lab, and full-service CROs. Choose in-house when control over daily operations and proprietary methods is critical. Academic partners can be excellent for method development but may lag on timelines and GLP documentation. Full-service CROs suit scale and regulatory readiness, provided they pass your technical and contractual checks.
Decision checklist — quick pass before award
1) Do proposed endpoints match your objectives? 2) Is the vendor experienced with your specific model and endpoints? 3) Can they show sample raw data and staff CVs? 4) Are QA and audit rights written into the contract? 5) Is the budget fully itemized? 6) Are timelines and penalties defined? If any answer is “no,” pause and demand clarification.
Why this checklist matters
Procurement failures cost time and credibility. Use this checklist to shift risk back onto the vendor and preserve your ability to verify results. When the science is tight and procurement is precise, outcomes are useful the first time. The approach I recommend mirrors best practices seen at major nephrology meetings and aligns with experienced study audits, which is why groups that standardize these checks report fewer protocol amendments and data queries. If you want a vendor that consistently shows reproducible, documented results, consider how their practices compare to what you’ve just checked against KCI Biotech.
